Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448

The Authors acknowledge the original list of individuals in HGSC CRS Collaborative Network outlined Appendix A. Supplementary Data was incomplete. complete is below, with previously omitted name bolded. authors would like to apologise for any inconvenience caused. Simi Aggarwal (Tata Medical Center, Kolkata, India), Holger Bronger (Technische Universität München, Germany), Elizabeth B Brown (Royal Devon and Exeter NHS Foundation Trust, Devon, United Kingdom), Martin Buck (Bendat Family Comprehensive Cancer Centre, St John God Subiaco Hospital, Subiaco, Australia), Syed Bukhari (Birmingham Women's Edwina Coghlan (University Notre Dame Australia, Fremantle, Nichola Cope Michelle Samora de Almeida (Federal University São Paulo, Brazil), Cornelius D. De Kroon (Leiden Leiden, Netherlands), Andrew Dean Michael-John Devlin (Barts Health Helena M. Ditzel Southern Denmark, Odense, Denmark), Enken Drecoll Munich, Takahiro Ebata (National Center Tokyo, Japan) Anna Fagotti (Fondazione Policlinico Gemelli. Università Cattolica del Sacro Cuore), Asma Faruqi (Bart's Laura Feeney (Northern Ireland Belfast, Kavita Gupta Ian Harley (Belfast Social Care Frediano Inzani Arjun R. Jeyarajah (Department Gynaecological Oncology, MH Eleanor Koay (King Edward Memorial Judith Kroep Jung-Yun Lee (Institute Life Science, Yonsei College Medicine, Seoul, Republic Korea), Yee Leung (Division Obstetrics Gynaecology, Faculty Medicine Sciences, Western Crawley, Lockley (Queen Mary London, Alice R Loft (Canterbury District Board, Christchurch, New Zealand), Daniel MaGee Dame, Ranjit Manchanda Trust), Sarah McKenna City Divya Midha David Millan Hospital Glasgow, Joanne Millar Rowan Miller Ganendra Mohan Sohail Mughal Asima Mukhopadhyay Sergio Mancini Nicolau James Nevin Abigail S. Oakley Quigley (Queen's Bhavana Rai (Postgraduate Institute Education Research, Chandigarh, Arvind Rajwanshi Stuart G. Salfinger Giovanni Scambia Cuore, Roma, Italy), Kate Scatchard Barbara Schmalfeldt Bryony Simcock (Christchurch Priya Singh Kyle C. Strickland (Duke Durham, State America), Vainta Suri Sheeba Peter Sykes Otago, Adeline Tan (Western Women's' Pathology, Diagnostic Wembley, Jason (WOMEN West Leederville, Kenji Tamura Japan), Emily Thompson British Columbia, Vancouver, Canada), V. Tinker (Vancouver General Giorgia Trevisan Maria Gabriela Baumgarten Kuster Uyeda Vaughan Canterbury, Wilko Weichert Anthony Williams Hiroshi Yoshida Pier Carlo Zorzato Italy). DOI article: https://doi.org/10.1016/j.ygyno.2019.04.679. Pathological chemotherapy response score prognostic tubo-ovarian high-grade serous carcinoma: A systematic review meta-analysis individual patient dataGynecologic OncologyVol. 154Issue 2PreviewThere a need develop validate biomarkers treatment survival carcinoma (HGSC). (CRS) stratifies patients into complete/near-complete (CRS3), partial (CRS2), no/minimal (CRS1) after neoadjuvant (NACT). Our aim current evidence determine whether women treated NACT. Full-Text PDF Open Access